SIRPA and glioblastoma: As expected, knockdown of LRIG2/sLRIG2 in GL261 (murine GBM) cells interferes with the activation of the CD47–SIRPα anti-phagocytic axis and enhances BMDM-mediated phagocytosis of GBM cells and suppresses GBM progression [99].